BioDelivery Sciences International Inc: Highlights
Financial data in U.S. dollars
| Financial Highlights |
|---|
| Sales |
108000.00 |
| Income |
-29.89 Mil |
| Net Profit Margin |
NA |
| Return on Equity |
NA |
| Debt/Equity Ratio |
NA |
|
| Revenue/Share |
0.01 |
| Earnings/Share |
-1.53 |
| Book Value/Share |
-1.96 |
| Dividend Rate |
0.00 |
| Payout Ratio |
NA |
|
| Revenue - Quarterly Results (in Millions) |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
| 1st Qtr | 0.0 | 0.1 | 0.0 |
| 2nd Qtr | 0.0 | 0.0 | 0.0 |
| 3rd Qtr | 0.0 | 0.0 | 0.0 |
| 4th Qtr | NA | 0.1 | 0.1 |
| Total | 0.0 | 0.3 | 0.2 |
| Earnings Per Share - Quarterly Results |
|---|
| | FY (12/09) | FY (12/08) | FY (12/07) |
| 1st Qtr | -$0.24 | -$0.17 | -$1.13 |
| 2nd Qtr | -$0.75 | -$0.17 | -$0.22 |
| 3rd Qtr | -$0.12 | -$0.14 | -$0.20 |
| 4th Qtr | NA | -$0.42 | -$0.23 |
| Total | -$1.11 | -$0.90 | -$1.78 |
| Qtr. over Qtr. EPS Growth Rate |
| FY (12/09) | FY (12/08) | FY (12/07) |
|---|
| 1st Qtr | 43% | 26% | --- |
| 2nd Qtr | -213% | 0% | 81% |
| 3rd Qtr | 84% | 18% | 9% |
| 4th Qtr | NA | -200% | -15% |
| Yr. over Yr. EPS Growth Rate |
| FY (12/09) | FY (12/08) |
|---|
| 1st Qtr | -41% | 85% |
| 2nd Qtr | -341% | 23% |
| 3rd Qtr | 14% | 30% |
| 4th Qtr | NA | -83% |
advertisement